Bioventus BVS
Bioventus Inc. · Nasdaq · Surgical & Medical Instruments & Apparatus
$10.95-16.77%close on Nov. 3, 2026 · volume 2.4M · Yahoo Finance
Price, last 51 sessions
Our coverage
Nothing published yet.
Insider buying and selling
No open-market insider buying or selling in the Form 4s filed since July 24, 2026.
Recent SEC filings
All 6 →Results of operations and financial condition · Financial statements and exhibits
AI summary, unreviewedBioventus Q3 2026 adjusted EPS of $0.17 beats $0.16 consensus, but revenue of $142.4 million misses $149.5 million estimate and full-year sales guidance of $590 million to $595 million sits below $604.8 million consensus
Results of operations and financial condition · Other events · Financial statements and exhibits